Squarepoint Ops LLC Tg Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

  • $99.2 Billion
  • Q4 2024

A detailed history of Squarepoint Ops LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 210,795 shares of TGTX stock, worth $8.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
210,795
Previous 48,713 332.73%
Holding current value
$8.1 Million
Previous $1.14 Million 456.98%
% of portfolio
0.01%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$21.31 - $35.09 $3.45 Million - $5.69 Million
162,082 Added 332.73%
210,795 $6.34 Million
Q3 2024

Nov 14, 2024
SELL
$17.21 - $25.28 $51,595 - $75,789
-2,998 Reduced 5.8%
48,713 $1.14 Million
Q2 2024

Aug 14, 2024
SELL
$13.32 - $19.19 $127,512 - $183,705
-9,573 Reduced 15.62%
51,711 $919,000
Q1 2024

May 15, 2024
SELL
$13.02 - $21.3 $3.44 Million - $5.63 Million
-264,540 Reduced 81.19%
61,284 $932,000
Q4 2023

Feb 14, 2024
BUY
$6.68 - $18.81 $2.18 Million - $6.13 Million
325,824 New
325,824 $5.57 Million
Q1 2023

May 15, 2023
SELL
$10.23 - $19.34 $163,209 - $308,550
-15,954 Reduced 19.19%
67,179 $1.01 Million
Q4 2022

Feb 14, 2023
SELL
$5.01 - $11.83 $165,355 - $390,449
-33,005 Reduced 28.42%
83,133 $983,000
Q3 2022

Nov 14, 2022
BUY
$4.57 - $8.4 $530,750 - $975,559
116,138 New
116,138 $688,000
Q1 2022

May 16, 2022
SELL
$7.81 - $20.45 $103,708 - $271,555
-13,279 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$15.2 - $35.51 $201,840 - $471,537
13,279 New
13,279 $252,000
Q2 2020

Aug 14, 2020
SELL
$8.9 - $21.84 $654,951 - $1.61 Million
-73,590 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$7.14 - $15.99 $525,432 - $1.18 Million
73,590 New
73,590 $724,000
Q3 2019

Nov 14, 2019
SELL
$5.38 - $8.99 $192,044 - $320,907
-35,696 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$6.27 - $8.65 $60,323 - $83,221
9,621 Added 36.9%
35,696 $309,000
Q1 2019

May 15, 2019
BUY
$4.02 - $8.04 $104,821 - $209,642
26,075 New
26,075 $210,000
Q3 2018

Nov 14, 2018
SELL
$5.15 - $14.0 $73,130 - $198,800
-14,200 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$12.5 - $15.0 $237 - $285
-19 Reduced 0.13%
14,200 $187,000
Q1 2018

May 15, 2018
SELL
$8.7 - $16.8 $32,668 - $63,084
-3,755 Reduced 20.89%
14,219 $202,000
Q4 2017

Feb 14, 2018
BUY
$7.35 - $12.3 $132,108 - $221,080
17,974
17,974 $147,000

Others Institutions Holding TGTX

# of Institutions
374
Shares Held
85.6M
Call Options Held
3.78M
Put Options Held
3M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5.58B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email